novartis ba d.o.o. - ofatumumab - rastvor za injekciju u napunjenom penu - 20 mg/0.4 ml - 1 napunjeni pen sadrži 20 mg ofatumumaba u 0,4 ml rastvora za injekciju (50 mg/ml)
novartis ireland ltd - ofatumumab - multipla skleroza, Рецидивно-Ремиттирующее - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.